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Abstract
Background—Contingency management (CM) is a widely recognized empirically-supported
addiction treatment; however, dissemination and adoption of CM into routine clinical practice has
been slow. Assessment of beliefs about CM may highlight key barriers and facilitators of adoption
and inform dissemination efforts. In the present study, we developed a 35-item questionnaire
(Contingency Management Beliefs Questionnaire; CMBQ) assessing CM beliefs and examined
the relation of these beliefs to clinician characteristics and clinical practices.
Methods—The web-based study was completed by 617 substance abuse treatment providers. We
examined the factor structure using exploratory factor analysis (EFA) in a randomly selected half-
sample (n =318) and evaluated the generalizability of the solution using confirmatory factor
analysis (CFA) in the second half-sample (n = 299).
Results—EFA results suggested a 3-factor solution with 32 items retained; factors represented
general barriers, training-related barriers, and pro-CM items. CFA results supported the solution,
and reliability was good within each half-sample (α = .88 and 0.90). Therapeutic approach, years
experience in addictions field, perception of CM’s research support, prior CM training, and CM
adoption interest were significantly associated with the factors.
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Conclusions—Overall, participants viewed CM favorably yet endorsed barriers, indicating a
need for more extensive and targeted response to the most common misperceptions in
dissemination efforts.
Keywords
contingency management; treatment barriers; dissemination; adoption; technology transfer
1. Introduction
Contingency management (CM) is an operant-based, empirically-supported treatment for
substance use disorders (Dutra et al., 2008; Lussier et al., 2006; Prendergast et al., 2006).
Clients earn reinforcers (e.g., prizes) by completing objectively verifiable behaviors such as
abstinence or treatment attendance. Like many empirically-supported treatments,
dissemination of CM within the addictions field has been slow (Miller et al., 2005). Studies
examining the use of empirically-supported treatments in substance abuse treatment
programs suggest that CM is often among the least familiar and utilized one (Benishek et al.,
2010; Herbeck et al., 2008; McGovern et al., 2004; Willenbring et al., 2004).
CM adoption has been hampered by a set of pervasive negative beliefs and attitudes.
Treatment providers often express moral/ethical objections, philosophical differences, and
concerns about its practicality (Cameron and Ritter, 2007; Henggeler et al., 2008; McCarty
et al., 2007; Petry and Bohn, 2003; Ritter and Cameron, 2007; Willenbring et al., 2004).
Treatment providers also believe CM is prohibitively costly, is unable to address underlying
issues driving substance abuse, inappropriately reinforces one behavior (e.g., abstinence
from a target drug) when other treatment goals are unmet (e.g., attendance, other drug use),
is disruptive to the treatment process or therapeutic relationship, undermines intrinsic
motivation to remain drug-free, and reflects bribery (Kirby et al., 2006).
As noted by Kirby and colleagues (2006 Kirby and colleagues (in press), many of these
beliefs reflect a limited understanding of CM and suggest that dissemination might best
focus on education efforts tailored to remediate the most often endorsed negative beliefs and
promote adherence to the basic behavioral principles underlying CM. Fortunately, others
(Petry and Bohn, 2003; Kellogg et al., 2005; Kirby et al., in press) have noted that once CM
implementation has begun and treatment providers observe changes, many of the negative
beliefs dissipate rapidly. These experiences (Petry and Bohn, 2003; Kellogg et al., 2005;
Kirby et al., in press) suggest that simple exposure may spur diffusion of CM. However,
Ducharme and colleagues (2007) did not find an effect of within-program CM exposure on
adoption likelihood, and Roman et al. (2010) note limited sustainability of implementation
following initial CM adoption. More work is needed to understand provider beliefs that
serve as potential barriers or facilitators to CM’s dissemination. Attitudes toward a treatment
can have major impacts on whether and how quickly diffusion occurs. The prominent role of
attitudes in models of technology transfer (Rogers, 2002; Simpson, 2002) suggests that
institutional and individual attitudes should not be overlooked in the adoption of new
interventions.
Two instruments (Henggeler et al., 2008; Kirby et al., 2006) have been developed to assess
barriers of CM dissemination. Henggeler et al. (2008) administered a questionnaire to
therapists following a CM training workshop. The questionnaire assessed the most frequent
institutional, philosophical, logistical, and clinical barriers to CM adoption, although it
contained few items related to training needs and competence-related issues. Kirby et al.
(2006) designed a questionnaire to assess beliefs about use of tangible and social reinforcers
by asking respondents to indicate their agreement with positive and negative attitudinal
Rash et al. Page 2
Drug Alcohol Depend. Author manuscript; available in PMC 2013 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
statements. The relationship of these statements was not linked to their interest in adopting
CM, thereby limiting the questionnaire’s ability to elucidate factors that might affect the CM
adoption process.
Drawing from existing questionnaires (Henggeler et al., 2008; Kirby et al., 2006), qualitative
interviews assessing CM barriers (Cameron and Ritter, 2007; Kellogg et al., 2005), and our
experience with CM in dissemination efforts, we developed an assessment tool to measure
beliefs about CM among substance abuse treatment providers in a web-based survey. The
questionnaire incorporated 1) the content domain breadth of the Henggeler et al. (2008) and
Kirby et al. (2006) questionnaires, 2) items related to training and competence barriers, and
3) a rating scale to assess the importance of each statement in participants’ decisions to
adopt CM. We assessed dimensionality, internal consistency, and stability of the
Contingency Management Beliefs Questionnaire (CMBQ) factor structure. To assess
concurrent validity, we examined whether prior exposure to CM predicted scores on CMBQ
factors. We predicted that training in and experience with CM would be inversely associated
with perceived barriers and positively associated with beliefs favorable to CM.
Demographic and clinical characteristics (e.g., therapeutic approach, years experience in
addictions field) that might be related to beliefs about CM were also evaluated.
2. Method
2.1 Participants
All participants (N = 617) self-identified as substance abuse treatment providers, defined as
individuals who treated one or more clients in the past year whose primary treatment goals
related to reducing substance use.
2.2 Measures
2.2.1 Participant characteristics—We assessed demographic (e.g., gender, age,
recovery status) and clinical characteristics (e.g., years experience in the field, therapeutic
approach, extent of training in CM). For potentially sensitive items such as recovery status,
we included a ‘prefer not to answer’ option.
2.2.2 Contingency Management Beliefs Questionnaire—We initially created a pool
of 56-items from prior studies (Cameron and Ritter, 2007; Henggeler et al., 2008; Kellogg et
al., 2005; Kirby et al., 2006) and personal experiences with CM dissemination. Six CM
experts (study authors and S.M. Alessi) rated each item for importance on a 5-point scale.
We retained 35 non-overlapping items with the highest average importance. These beliefs
related to 1) CM’s effectiveness, 2) institutional issues, 3) clinical concerns, 4) philosophical
concerns, 5) training/competence issues, 6) logistical barriers, and 7) CM-supportive
statements. Participants rated each item on a 5-point Likert scale (“no influence at all” to
“very strong influence”) according to how influential each item was to their interest in
adopting CM.
2.3 Procedures
We distributed an internet link to the web-based survey to email lists of providers and
professional organizations web pages (e.g., New York State Association of Alcoholism and
Substance Abuse Providers; National Association of Lesbian, Gay, Bisexual, and
Transgender Addictions Professionals; Addictive Behaviors Special Interest Group of the
Association of Behavioral and Cognitive Therapies). Recruitment was widespread and
accessed participants from 30 states. As approved by the university’s Institutional Review
Board, written consent was waived, but all participants indicated consent electronically
before accessing the survey. Participants could opt to submit their name and contact
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information for entry in a drawing for one of four $100 gift certificates for study
participation. Information from the drawing was stored separately and had no link to the
survey data. To limit multiple submissions by the same respondent, only one submission per
computer was permitted. In addition to the ‘prefer not to answer’ options, we prompted
skipped answers to reduce missing data.
2.3.1 Data analysis—We randomly selected approximately 50% of the sample (n = 318)
to examine the CMBQ’s factor structure using exploratory factor analysis (EFA). We then
used confirmatory factor analysis (CFA) to validate the solution in the second half-sample (n
= 299). For EFA and CFA analyses, we used a maximum likelihood estimator with standard
errors robust to nonnormality. We evaluated model fit using the Satorra-Bentler chi-square,
the root mean square error of approximation (RMSEA), and the standardized root mean
residual (SRMR). Values approaching zero indicate better fitting models for both the
RMSEA and SRMR. Common guidelines for RMSEA suggest values >0.10 indicate poor
fit, <0.08 indicate acceptable fit, and <0.05 indicate close fit (Browne and Cudeck, 1992).
SRMR values <0.10 are generally considered acceptable (Hu and Bentler, 1999).
The EFA was conducted using an oblique (promax) rotation. We anticipated up to a 7-factor
solution corresponding with the seven content domains we believed comprised the CMBQ,
but we examined a range of factor solutions (Fabrigar et al., 1999). The scree plot (Cattell,
1966), Velicer’s (1976) minimum average partial (MAP) test, parallel analysis (Horn, 1965),
model fit, and solution interpretability informed the range of retained factors. The MAP test
and parallel analysis (with 1000 raw data permutations) were conducted using syntax from
O’Connor (2000). A priori retention criteria for items were factor loadings of 0.32 or greater
on a primary factor and low (< .30) loadings on all other factors (Tabachnick and Fidell,
2001).
3. Results
3.1 Questionnaire Completion
Of the 728 individuals consenting to participate, 111 terminated the study early (during
demographics) and did not provide any data on the CMBQ. Using available data from
noncompleters (n = 70–111 depending on variable), we compared completers (N = 617) and
noncompleters for differences in demographic and background characteristics. The groups
did not differ in terms of age, recovery status, perception of CM’s research support,
treatment setting (e.g., inpatient, outpatient), or personal therapeutic approach (all ps > .05).
Completers were more likely to be male, χ2(1, n = 704) = 5.55, p = .018, and have personal
experience with CM, χ2(1, n = 728) = 11.63, p = .001, than noncompleters. Remaining
analyses used data from completers (N = 617) only. Missing data (i.e., skipped questions)
were minimal (<6%) for completers.
3.2 Treatment Provider Characteristics
Table 1 provides demographic and clinical characteristics for the two randomly selected
half-samples of providers. The half-samples were similar in terms of gender, age, years
experience in the addictions field, recovery status, treatment setting, therapeutic approach,
and personal experience with CM (ps > .05). About 50% of participants reported some
experience using reinforcers with clients; however, most (72%, 214/296 individuals
reporting experience with reinforcers) used no cost or very low cost reinforcement (< $25
per client) and nearly all (90%) reported using magnitudes below $100 per client.
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3.3 Exploratory Factor Analysis
Initial review (MAP test, parallel analysis, etc.) suggested a final solution containing 2–6
factors. The 4, 5, and 6 factor solutions each contained one factor with no substantially
loading items. The 2-factor and 3-factor solutions produced viable results. In the 2-factor
solution, simple structure was obtained with all CM barriers loading on the primary factor
and all pro-CM items loading on the second factor.
Table 2 displays factor loadings for the 3-factor solution, which had a significantly
improved fit relative to the 2-factor model, Satorra-Bentler (2001) scaled Δχ2(33) = 255.20,
p < .001. Items are ordered by highest mean endorsement within each factor and significant
factor loadings are underlined. We retained 32 of the 35 items based on a priori criteria
(excluded items located at bottom of Table 2). The 3-factor solution represented a primary
factor (F1) containing all barriers except training-related barriers, which loaded on the
second factor (F2). All pro-CM items loaded on the third factor (F3).
Given improved model fit compared to the 2-factor solution and evidence that F2 items
related to the F1 and F3 factors differently, we proceeded with the 3-factor solution. The
final 3-factor, 32-item model had acceptable fit: Satorra-Bentler χ2(403) = 851.15, p < .001,
RMSEA = 0.059, SRMR = 0.045. The items accounted for 96%, 91%, and 97% of the
variance in each factor, respectively. F1 (general barriers) and F2 (training barriers)
correlated significantly, r (n = 318) = 0.44, p < .001. F3 (pro-CM items) was not correlated
with F1 (r = −0.04), but correlated moderately with F2, r = 0.10, p = .02. Mean inter-item
correlations and ranges were 0.33 (0.11–0.65), 0.47 (0.27–0.66), and 0.53 (0.34–0.86) for
F1, F2, and F3, respectively. Reliability for the whole scale (Chronbach’s α = 0.88) and each
of the individual factors was adequate (F1: α = 0.90; F2: α = 0.78; F3: α = 0.92). Deletion of
item 31 (‘agency support’) would increase alpha of F2 to 0.82; however, given the small
number of items loading on F2 and the acceptable factor loadings and inter-item
correlations, we chose to retain this item.
As displayed in Table 2, F1 statements with highest mean endorsement included item 20
(“worried about what happens once contingencies are withdrawn”), item 8 (“CM is
expensive”), and item 1 (“research evidence does not apply to everyday clinic populations”).
For F2, item 16 (“want more training before implementing CM”) and item 27 (“no one has
experience to supervise CM”) were the highest endorsed statements. Among pro-CM
statements, item 6 (“useful for goals other than abstinence”), item 18 (“any source of
motivation is good”), and item 35 (“keeps clients engaged long enough to learn valuable
skills”) were among the highest endorsed items. Overall, mean within-person ratings for
pro-CM statements (M = 3.46, SD = 0.91) were higher than barrier items (ps < .001; F1: M =
2.42, SD = 0.71; F2: M = 2.86, SD = 1.06).
3.4 Confirmatory Factor Analysis
Using CFA, we examined the generalizability of the 3-factor, 32-item EFA solution in the
second randomly selected half-sample (n = 299). Factor variances were fixed to one and
factor loadings were freely estimated. Table 2 displays factor loadings and R-squared for
each item. All factor loadings exceeded 0.32 with the exception of item 1 (‘research
evidence does not apply to clinic populations’), which had a factor loading of 0.30. About
70% of providers reported that this item has some, strong or very strong influence in their
decision to adopt CM. This substantial endorsement suggests that even treatment providers
familiar with CM’s research support may discount this research as inapplicable to everyday
clinic populations. Despite the low CFA factor loading, we chose to retain the item given its
conceptual importance to CM diffusion efforts and satisfactory loading in the EFA.
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The CFA model fit was reasonable, χ2(461) = 1017.02, p < .001, RMSEA = 0.064, SRMR =
0.079, but modification indices suggested significant correlation in the error variances of
adjacent pro-CM items (F3). With the addition of these error covariances, model fit
improved, χ2(455) = 827.03, p < .001, RMSEA = 0.052, SRMR = 0.077. Correlations
between F1 and F2 (0.70, SE =0.04) and F2 and F3 (0.15, SE =0.08) were significant. Inter-
item correlations and ranges for the second half-sample were 0.37 (0.05–0.66), 0.45 (0.23–
0.59), and 0.59 (0.43–0.88) for F1, F2, and F3, respectively. Reliabilities were acceptable
for the whole scale (Chronbach’s α = 0.90) and each of the individual factors (F1: α = 0.91;
F2: α = 0.77; F3: α = 0.94). Within-person means across the three factors differed
significantly (ps < .001). Participants endorsed higher means for the pro-CM factor (M =
3.47, SD = 0.91) than general barriers (M = 2.45, SD = 0.74) or training barriers (M = 2.88,
SD = 1.01).
3.5 Covariate Models
We examined factor associations with selected covariates: age, years experience in
addictions field, personal therapeutic approach (12-step [referent], cognitive-behavioral
treatments [CBT], Motivational, Other), recovery status (not in recovery [referent], in
recovery, prefer not to answer), CM used in clinic (none versus any), personal experience
with CM (none versus any), extent of prior CM training, and CM adoption interest. We first
assessed whether individual covariates independently predicted the scores on the three
factors. We eliminated recovery status from further models given nonsignificant associations
with all three factors in these single covariate models. The remaining covariates were
entered simultaneously, with the three CMBQ factors regressed on all covariates.
Table 3 presents the standardized regression coefficients (RMSEA = 0.06, SRMR = 0.07).
Underlined coefficients indicate significant paths. Relative to participants reporting a
predominantly 12-step approach, individuals reporting CBT and motivational approaches
were less likely to endorse both general (F1) and training (F2) barriers to CM adoption.
Those with ‘other’ therapeutic approaches responded similarly as compared to individuals
endorsing a 12-step approach for general (F1) barriers, but were less likely to endorse
training (F2) barriers. Prior training in CM was negatively associated with both barriers
factors (F1, F2), and those with prior CM experience were less likely to endorse training-
related (F2) barriers. Interest in adopting CM was negatively associated with general barriers
(F1) and positively associated with training barriers (F2) and pro-CM (F3) factors.
4. Discussion
The present study developed a questionnaire of beliefs about CM in relationship to provider
interest in adopting this practice, established its psychometric properties, and examined the
association of provider characteristics to the derived factors. The study had three main
findings. First, the CMBQ demonstrated stable, reliable psychometric properties across
randomly selected half-samples. Second, treatment providers viewed CM favorably, even
while acknowledging several adoption barriers. Third, several variables were associated
with CM beliefs, including prior CM training, experience with CM, interest in adopting CM,
and treatment allegiance.
EFA and CFA results of the CMBQ supported a 32-item, 3-factor structure corresponding to
general barriers, training-related barriers, and CM-supportive statements. The measure was
stable and reliable across the half-samples. Despite generally favorable views of CM,
participants endorsed a number of influential barriers including: 1) the applicability of CM’s
research support to clinic populations, 2) clients’ behavior after the contingencies are
withdrawn, and 3) expense of CM. Beliefs that CM undermines internal motivation and does
not address the underlying cause of addiction, although pertinent, were not among the top
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endorsed barriers as found in the Kirby et al. (2006 Kirby et al. (in press) studies. Difference
across studies may be a product of sampling, a reflection of ongoing education regarding
CM, or related to different rating scales (i.e., agreement in Kirby et al. [2006, in press]
versus influence on adoption in the present study). If related to rating scales, these
differences across studies may imply that philosophical barriers, while highly prevalent, are
less influential in decisions to adopt CM. We note that many of the barriers (e.g., research
applicability, logistical barriers, leadership support) are common to other treatments (Roman
et al., 2010; Willenbring et al., 2004). Training efforts will likely need to address both these
global barriers and those more specific to CM.
Addressing common misperceptions early in dissemination efforts may facilitate adoption.
For example, training might address the applicability of CM’s research to typical client
populations by emphasizing that much of CM’s research has been conducted in community
substance abuse treatment clinics (Lott and Jencius, 2009; Peirce et al., 2006; Petry et al.,
2000; 2004; 2005a; 2005b; 2006). Further, providers’ attention might be drawn to research
suggesting that CM appears to work equally well and in some cases better in populations
viewed as highest risk for treatment failure, such as those with multiple substance disorders,
prior treatment attempts, and psychiatric comorbidities (Alessi et al., in press; Byrne and
Petry, 2011; Ford et al., 2007; Rash et al., 2008ab; Weinstock et al., 2007). Fortunately, our
results suggest that prior training is associated with less endorsement of CM barriers.
Interestingly, prior CM experience was associated with fewer training-related barriers, but
not general barriers. These results are consistent with the findings of Ducharme et al. (2007)
who found no effect of exposure to CM on adoption likelihood. Future work might assess
the extent that training and experience in CM is effective in changing beliefs, as well as
whether this questionnaire is sensitive to change over time.
Interest in adopting CM was associated more with positive beliefs about CM and recognition
of training and competence needs than perceptions of general barriers. This recognition of
training needs bodes well for the careful development and execution of CM protocols that
are consistent with behavioral principles. In this study, many providers reported
incorporating reinforcers in their practice (e.g., certificates of completion, group leadership
status). About 50% of providers indicated that they used CM with clients; however, 72% of
these providers indicated that their total amount of reinforcement available per client was
less than $25. These practices indicate recognition of the potential value of reinforcement;
however, magnitude of reinforcement is an important parameter in the efficacy of CM
(Lussier et al., 2006). Unaware providers may develop negative attitudes toward CM when
rewards do not produce expected results. Educational efforts need to clearly delineate the
differences between the use of rewards versus a systematic application of reinforcement via
CM. Materials that stress these differences, including the importance of specific parameters
(e.g., magnitude, frequency, and immediacy of reinforcement), may yield better CM
protocols and outcomes.
Among clinical characteristics, allegiances to CBT and motivational enhancement
approaches were related to less endorsement of CM barriers, while practitioners identifying
12-step as their primary treatment approach endorsed greater barriers. These results are
consistent with those of Ducharme et al. (2010) who identified 12-step allegiance as a
significant barrier to use of tangible reinforcers. Such findings represent a challenge to CM
dissemination given the dominance of 12-step approaches in the United States addiction
treatment system (Roman and Johnson, 2004). Fortunately, provider attitudes toward new
approaches can change with brief education presentations, even among those with 12-step
treatment allegiance (Goddard, 2003).
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Although this study focused on providers’ beliefs regarding CM, middle and upper
management attitudes will also be important to adoption of new technologies (Simpson,
2002). Without adequate support (i.e., provision of training for staff, recognition of time
demands), clinical staff are unlikely to successfully implement CM. In addition, providers
may also have to contend with negative public opinion about CM. Harm reduction
strategies, such as needle exchange and supervised injection sites, face similar obstacles
(e.g., Anderson, 1991), but experience with these strategies appears to ameliorate many
concerns (Salmon et al., 2007; Thein et al., 2005). Public opinion change about CM will
likely be driven by educational materials challenging misperceptions, as well as highlighting
the cost-effectiveness of CM and ethical considerations of withholding efficacious
treatments. System-level changes, including the ability to integrate CM within existing
payment systems, are needed. As noted by Roll et al. (2009), behavioral interventions for
autism faced considerably difficulties in gaining recognition by payors, but ultimately
succeeded through community education and persistent grass-roots efforts. These
experiences may provide guidance for CM-related initiatives.
Strengths of this study were the inclusion of a large, nationwide sample of treatment
providers representing those with and without prior exposure to CM. The large sample
permitted assessment of the stability of the CMBQ factor structure using separate half-
samples, which supports factor structure generalizability. This questionnaire builds on prior
measures by expanding coverage of barriers and assessing these barriers in relation to
adoption interest. Administrators may find the CMBQ useful as an agency-level measure of
providers’ barriers. Education materials and trainings could then be tailored to address the
most commonly raised concerns within the agency.
Limitations included: 1) use of a web-based survey may reduce generalizability of the
results due to sampling bias (e.g., volunteer effect); 2) early termination of the survey
occurred in about 15% of the respondents and these respondents were less likely to have
experience with reinforcers than those who continued; 3) many of the respondents may have
been solicited from email list serves maintained by CM experts, biasing the sample to more
CM-experienced providers who may have more favorable impressions toward CM than
addiction providers as a whole, and 4) the sample had relatively few providers who
identified 12-step as their primary approach. The use of an on-line survey and the
recruitment strategies may have predisposed the sample towards clinicians at academic
medical centers and hospitals. Individuals in these settings may be more receptive to and
aware of research developments, including those related to CM, and may have skewed the
sample toward favorable impressions of CM. The underrepresentation of clinicians with 12-
step orientations may also be related to methodological approach. Further validation of the
questionnaire is needed using representative samples, including those with larger
proportions of 12-step providers, those with less CM experience, and administrators.
Additional research should also address whether similar relationships between prior training
and CM experience exist in samples with less favorable opinions about CM.
Nonetheless, this study developed a questionnaire of positive and negative beliefs about CM
and assessed the influence of these beliefs on decisions to adopt CM into clinical practice.
The questionnaire was stable and reliable across randomly selected half-samples. Results
suggested that providers in this sample view CM favorably overall, although they
maintained a number of misperceptions. Ongoing educational efforts can target these
barriers while simultaneously highlighting the advantages of CM to more effectively
promote the adoption of CM in community substance abuse treatment programs.
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Table 1
Demographic and Background Characteristics for the Randomly Selected Half-samples
Variable EFA Sample (n = 318) CFA Sample (n = 299) Statistic p
Female 67% 64% χ2(1) = 0.41 .52
Age (years) χ2(4) = 2.93 .57
 18–30 14% 12%
 31–40 21% 23%
 41–50 27% 22%
 51–60 27% 31%
 Over 60 11% 12%
Years experience in addictions χ2(4) = 3.37 .50
 ≥ 1 year 6% 7%
 2–5 years 24% 23%
 6–10 years 23% 18%
 11–20 years 28% 27%
 > 20 years 20% 24%
Recovery status χ2(2) = 2.58 .28
 Not in recovery 66% 72%
 In recovery 27% 23%
 Prefer not to answer 7% 5%
Treatment setting χ2(3) = 0.04 1.0
 Methadone Maintenance Clinic 12% 11% 0
 Residential/inpatient SA 25% 26%
 Outpatient SA 40% 39%
 Other 24% 24%
Personal therapeutic approach χ2(3) = 7.50 .06
 12-step 8% 11%
 Cognitive Behavioral 52% 46%
 Motivational Enhancement 21% 27%
 Other 20% 16%
Any prior experience using reinforcers 50% 46% χ2(1) = 0.77 .38
Extent of prior CM training χ2(6) = 4.08 .66
 None 42% 46%
 Less than 1 hour 11% 9%
 1–2 hours 14% 15%
 3–5 hours 10% 11%
 6–8 hours 8% 6%
 9–16 hours 4% 3%
 More than 16 hours 10% 10%
Of those with prior reinforcer experience: n = 158 n = 138
Type of reinforcer useda
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Variable EFA Sample (n = 318) CFA Sample (n = 299) Statistic p
 Social (non-monetary) 62% 67% χ2(1) = 0.93 .34
 Clinic privileges 31% 40% χ2(1) = 2.53 .11
 Vouchers 10% 12% χ2(1) = 0.61 .44
 Prizes 43% 37% χ2(1) = 1.13 .29
Typical magnitudes of available reinforcement (per client)b χ2(8) = 7.72 .46
 $0 (non-monetary reinforcement only) 38% 47%
 Less than $10 16% 11%
 $10–25 15% 17%
 $25–50 11% 7%
 $50–100 9% 9%
 $100–300 4% 6%
 $300–500 3% 1%
 More than $500 2% 1%
Target behaviorsa
 Attendance 84% 75% χ2(1) = 3.05 .08
 Abstinence 60% 59% χ2(1) = 0.02 .90
 Activities 39% 38% χ2(1) = 0.02 .88
 Clinic behaviors 55% 50% χ2(1) = 0.76 .38
Notes.
a
Respondents could select more than one option.
b
Percentages do not add to 100% due to missing data. EFA and CFA samples were randomly selected half-samples from the total 617 participants.
Participants were self-identified substance abuse treatment professionals. EFA = exploratory factor analysis, CFA = confirmatory factor analysis,
SA = substance abuse.
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Table 3
CFA Model Regression Coefficients (n = 299)
Covariates Factor 1: General
Barriers
Factor 2: Training-
related Barriers
Factor 3: Pro-CM
Items
Age −0.07 −0.08 −0.01
Years experience in addiction field −0.08 0.04 −0.05
Personal therapeutic approach (12-step = referent)
 Cognitive Behavioral −0.41 −0.60 −0.29
 Motivational Enhancement −0.61 −0.35 −0.08
 Other −0.23 −0.50 −0.34
CM used by other clinicians at primary worksite (relative to
none)
−0.001 −0.002 −0.002
Prior experience using reinforcers (relative to none) −0.16 −0.55 −0.09
Amount of prior CM training −0.28 −0.38 0.06
CM adoption interest −0.13 0.16 0.57
Notes. Underlined standardized coefficients are significant at p < .05.
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